Life Sciences Collaborative
The Life Sciences Collaborative (LSC) is a select group of founders and investors that share a common vision for enhancing the success of emerging businesses in the biotechnology, medtech, and digital health sectors through peer-to-peer learning, connecting and building professional relationships.
The Collaborative has built thriving groups over the last ten years in the Princeton, NJ, Philadelphia/King of Prussia, PA, and most recently in Boston, MA, regions all of which are homes to leading life science innovation clusters.
One of the Collaborative’s great strengths is the opportunity for members to build connections across these key regions
Who we are
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors, and industry service providers who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
The meetings also include presentations by emerging companies, providing them with opportunities to get expert feedback on their technologies and to expand their networks.
Mission Statement
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional development and business growth in the Mid-Atlantic Region.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.
OUR MEMBERS
CEOs, Directors, Private Equity and Venture partners, Angel investors. Members may have successful track record leading public or private companies.
Baber Ghauri
Healthcare Desperado
Brandy Houser, PhD
Co-Founder at Traverse Biotech
Christopher J. Schaber
PhD – CEO, SOLIGENIX, Inc.
Dan Conley
OnCallCFO for Fundable Teams; Angels
Glenn Whaley
Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Ira Spector
CEO at SFA Therapeutics, Inc
Jerry Ruddle
CEO at NewIV Medical Corp
Joe Camaratta
President and CEO at Quantaras